A phase II study evaluating the use of concurrent mitomycin C and capecitabine in patients with advanced unresectable pseudomyxoma peritonei
about
A new standard of care for the management of peritoneal surface malignancyThe impact of stage, grade, and mucinous histology on the efficacy of systemic chemotherapy in adenocarcinomas of the appendix: Analysis of the National Cancer Data BasePerioperative systemic chemotherapy for appendiceal mucinous carcinoma peritonei treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapyFOLFOX-4 chemotherapy for patients with unresectable or relapsed peritoneal pseudomyxoma.Bevacizumab for the Treatment of Non-Resectable Pseudomyxoma peritonei Associated with Mucinous Ovarian Tumor of Low Malignant Potential - A Comparison of Two Cases.Global gene expression in pseudomyxoma peritonei, with parallel development of two immortalized cell lines.Systemic chemotherapy and surgical cytoreduction for poorly differentiated and signet ring cell adenocarcinomas of the appendix.GNAS mutations as prognostic biomarker in patients with relapsed peritoneal pseudomyxoma receiving metronomic capecitabine and bevacizumab: a clinical and translational studyPeritoneal carcinomatosis of gastrointestinal origin: natural history and treatment options.Mucinous adenocarcinomas with intra-abdominal dissemination: a review of current therapy.Peritoneal cancer treatment.Pseudomyxoma peritonei metastatic to the bone: case report and review of systemic management.Appendiceal Mucinous Neoplasms: Diagnosis and Management.Pathologic complete response in poorly differentiated adenocarcinomas of the appendix: a case series.Impact of aggressive histology and location of primary tumor on the efficacy of surgical therapy for peritoneal carcinomatosis of colorectal origin.The role of perioperative systemic chemotherapy in diffuse malignant peritoneal mesothelioma patients treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.The pre-operative neutrophil-lymphocyte ratio predicts overall and disease-free survival following cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) in patients with pseudomxyoma peritonei of appendiceal origin.Circulating tumor markers: predictors of incomplete cytoreduction and powerful determinants of outcome in pseudomyxoma peritonei.Recommendations in the management of epithelial appendiceal neoplasms and peritoneal dissemination from mucinous tumours (pseudomyxoma peritonei).
P2860
Q24626790-C2A91719-6804-461E-A5E8-8275843041BAQ31011907-9507DF0A-1AED-4C2D-9857-C32C3A2F1631Q33569361-6377DBE9-0CA4-4BA5-A14F-12A93E820D34Q34005136-848C5147-EBA2-482A-9013-1411AB8C9256Q34054735-1F252896-E4E5-4DE6-9347-757C8CECEED3Q35619533-9ADFE41B-A67C-4778-BDD8-842BE466BB88Q35902817-74184AC6-1C9A-4B4F-9DD3-B2D28FA552CCQ36879706-2CE80195-2DFF-454F-9252-2DB12EE78790Q37528436-F10009F1-4487-44E7-BF7F-EC73F36A5775Q37775430-CF8859D1-475F-4848-9003-5A5D9F8D4A0AQ38195114-6A80B403-A8EB-4FB7-939A-AC0FF28F8A51Q38256152-7DB69EF0-28A5-417E-A71F-5C1DFE92E0F4Q38701575-57BC360F-3DB9-4692-B402-3FF69BF41BD4Q43941175-C7B94764-752E-4DDC-828C-65A092AA90EEQ44892132-2B5C7CAC-A55C-4789-9C90-3A90566A4634Q45952963-A9AFB2F9-91B7-4588-B3BC-D187D0C084BFQ48139507-2C48ACD3-3AE8-4443-9306-DB172B374A32Q50951335-A40412AE-1292-4CA9-9A2E-8059335BF862Q53304239-5881835B-3FB7-4CA6-86E8-0F99C2481250
P2860
A phase II study evaluating the use of concurrent mitomycin C and capecitabine in patients with advanced unresectable pseudomyxoma peritonei
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
A phase II study evaluating th ...... ectable pseudomyxoma peritonei
@en
type
label
A phase II study evaluating th ...... ectable pseudomyxoma peritonei
@en
prefLabel
A phase II study evaluating th ...... ectable pseudomyxoma peritonei
@en
P2093
P2860
P356
P1476
A phase II study evaluating th ...... ectable pseudomyxoma peritonei
@en
P2093
A L Farquharson
M B Taylor
M P Saunders
M S Wilson
R Swindell
S T O'Dwyer
P2860
P2888
P304
P356
10.1038/SJ.BJC.6604522
P407
P577
2008-08-01T00:00:00Z